Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) News
Latest headlines that mention MDGL, newest first · each headline opens the original publisher
- Last price
- $449.74
- Day change
- -2.19%
- Next earnings
- 2026-11-03
MDGL headlines
latest coverageMadrigal has a first-mover advantage in treating MASH, a type of fatty liver disease.
Rezdiffra's biggest growth opportunity may still be ahead.
MDGL news alerts
Get an alert by email or push when a new headline mentions MDGL.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.